Literature DB >> 16945899

Temporomandibular disorders, headaches, and cervical pain among females in a Sami population.

Christina Storm1, Anders Wänman.   

Abstract

OBJECTIVE: The aim of this study was to examine the prevalence and co-morbidity of long-standing, intense, and frequent symptoms of pain and dysfunction in the jaw-face, head, and cervical region among adult females drawn from the Sami population in northern Sweden.
METHODS: A total of 487 females, taken from the register of the Swedish Sami Parliament or registered as reindeer owners or reindeer herders in the Swedish Board of Agriculture and living in the Arctic region of northern Sweden, participated in a questionnaire study.
RESULTS: The prevalence of pain and/or dysfunction in the jaw-face region was 32%, of headaches 61%, and of pain in the cervical region 56%. When the criterion of frequent symptoms (once a week or more often) was used, prevalence dropped to 17%, 19%, and 30%, respectively, and when that of intense symptoms, defined as 5 or more on an 11-point numerical rating scale, was added, prevalence dropped further to 8%, 11%, and 20%, respectively. The majority reported long-standing symptoms (67-98% depending on symptom). A high statistically significant relationship was found between frequent symptoms of pain and/or dysfunction in the jaw-face, frequent headaches, and frequent cervical pain (p<0.0001).
CONCLUSIONS: Symptoms in the jaw-face, headaches, and cervical pain were frequently reported among a sample of Sami females living in the Swedish Arctic region. The prevalence of symptoms was strongly dependent on criteria of frequency and intensity.

Entities:  

Mesh:

Year:  2006        PMID: 16945899     DOI: 10.1080/00016350600801915

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  9 in total

1.  Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders.

Authors:  Gülşen Kocaman; Neşe Kahraman; Banu Gürkan Köseoğlu; Başar Bilgiç; Zeliha Matur; Mustafa Ertaş; Yeşim Gülşen; Betül Baykan Baykal
Journal:  Noro Psikiyatr Ars       Date:  2018-07-06       Impact factor: 1.339

Review 2.  Chronic orofacial pain.

Authors:  Sowmya Ananthan; Rafael Benoliel
Journal:  J Neural Transm (Vienna)       Date:  2020-03-04       Impact factor: 3.575

Review 3.  Chronic orofacial pain.

Authors:  Rafael Benoliel; Yair Sharav
Journal:  Curr Pain Headache Rep       Date:  2010-02

Review 4.  Temporomandibular disorders and migraine chronification.

Authors:  Debora Bevilaqua Grossi; Richard B Lipton; Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2009-08

5.  Effects of tailored neck-shoulder pain treatment based on a decision model guided by clinical assessments and standardized functional tests. A study protocol of a randomized controlled trial.

Authors:  Martin Björklund; Mats Djupsjöbacka; Asa Svedmark; Charlotte Häger
Journal:  BMC Musculoskelet Disord       Date:  2012-05-20       Impact factor: 2.362

6.  Is tailored treatment superior to non-tailored treatment for pain and disability in women with non-specific neck pain? A randomized controlled trial.

Authors:  Åsa Svedmark; Mats Djupsjöbacka; Charlotte Häger; Gwendolen Jull; Martin Björklund
Journal:  BMC Musculoskelet Disord       Date:  2016-09-30       Impact factor: 2.362

7.  Somatic health in the Indigenous Sami population - a systematic review.

Authors:  Christina Storm Mienna; Per Axelsson
Journal:  Int J Circumpolar Health       Date:  2019-12       Impact factor: 1.228

8.  Does a dose-response relation exist between spinal pain and temporomandibular disorders?

Authors:  Birgitta Wiesinger; Hans Malker; Erling Englund; Anders Wänman
Journal:  BMC Musculoskelet Disord       Date:  2009-03-02       Impact factor: 2.362

9.  The relationship between spinal pain and temporomandibular joint disorders in Korea: a nationwide propensity score-matched study.

Authors:  Doori Kim; Seong-Gyu Ko; Eun-Kyoung Lee; Boyoung Jung
Journal:  BMC Musculoskelet Disord       Date:  2019-12-29       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.